Back to Newsroom

Clinical Data for BackBeat Medical’s Programmable Hypertension Control Therapy to Be Presented at TCT 2016

NEW HOPE, Pa., Oct. 26, 2016 /PRNewswire/ — BackBeat Medical Inc. today announced that clinical data for the company’s patented Programmable Hypertension Control (PHC) therapy for the treatment of hypertension will be presented at Transcatheter Cardiovascular Therapeutics (TCT) 2016, Oct. 29-Nov. 2, in Washington.

Click here to read the full release